Skip to main content
Premium Trial:

Request an Annual Quote

Sophia Genetics, Hitachi Partner on Data-Driven Precision Medicine

NEW YORK – Sophia Genetics and Hitachi said on Thursday that they have signed a long-term collaboration deal to extend data-driven precision medicine to healthcare providers and pharmaceutical companies worldwide.

The companies said that they would initially cooperate to expand the reach of Sophia's core DDM analytics platform and various Hitachi digital healthcare offerings, including its molecular tumor board support service, in "key geographies." They also hope to collaborate on secure personal genomics data management, data-driven clinical decision support, and the acceleration of drug development in oncology and other areas, as well as to codevelop new products in the longer term.

"This partnership will enable us to broaden our commercial reach and support improved health outcomes for more patients," Jurgi Camblong, CEO of Lausanne, Switzerland-based Sophia, said in a statement.

"Hitachi is excited to start [a] long-term partnership with Sophia Genetics to co-create innovative solutions for improving quality of life of patients by leveraging both companies' data analytics and AI technologies," added Keiji Kojima, executive VP and executive officer of Hitachi and general manager of its Smart Life Business Management Division.

Hitachi's investment arm, Hitachi Ventures, already has an equity stake in Sophia. The Japanese firm co-led a $110 million investment round in Sophia last year.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.